BCAL Takes Interest in Genetic Signatures to 18.46%
Filed with ASX · · 2 pages · English
BCAL Diagnostics Limited on 6ix
Story so far
Earlier from BCAL Diagnostics
- Change in Substantial Shareholder Notice for GSS
- Notification regarding unquoted securities - BDX
- BCAL Secures Funding for FY2027 Update
- Proposed issue of securities - BDX
- Bioshares Conference Investor Presentation
Later from BCAL Diagnostics
- Appendix 4G and Corporate Governance Statement
- Appendix 4E and Annual Report to shareholders
- Meet The CEO FY 2026 Results Webinar 3 Sept 2026 at 1PM
- Investor Presentation September 2026
- BCAL Seeks Board Change at Genetic Signatures
Follow BCAL Diagnostics into a list and get an email when it puts out news.
Follow BCAL Diagnostics